Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jane Gross

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Plos Pathogens|September 20, 2008
Interleukin-17A mediates acquired immunity to pneumococcal colonizationYing-Jie Lu, Jane Gross, Debby Bogaert, et al.
Pediatric Pulmonology|August 29, 2019
American Thoracic Society 2019 Pediatric Core CurriculumPaul E Moore, Debra Boyer, Ryan Perkins, et al.
Molecular Cancer Therapeutics|November 7, 2022
The Bispecific Tumor Antigen-Conditional 4-1BB x 5T4 Agonist, ALG.APV-527, Mediates Strong T-Cell Activation and Potent Antitumor Activity in Preclinical StudiesMichelle H Nelson, Sara Fritzell, Robert Miller, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Plos Pathogens|September 20, 2008
Interleukin-17A mediates acquired immunity to pneumococcal colonizationYing-Jie Lu, Jane Gross, Debby Bogaert, et al.
Pediatric Pulmonology|August 29, 2019
American Thoracic Society 2019 Pediatric Core CurriculumPaul E Moore, Debra Boyer, Ryan Perkins, et al.
Molecular Cancer Therapeutics|November 7, 2022
The Bispecific Tumor Antigen-Conditional 4-1BB x 5T4 Agonist, ALG.APV-527, Mediates Strong T-Cell Activation and Potent Antitumor Activity in Preclinical StudiesMichelle H Nelson, Sara Fritzell, Robert Miller, et al.
Pageof 1